Dysregulation of the p53 Pathway Provides a Therapeutic Target in Aggressive Pediatric Sarcomas with Stem-Like Traits

Investigators showed that restoring canonical p53 activity provided a promising strategy for developing improved therapies for pediatric sarcomas with unfavorable stem-like traits.